Teva Releases Q2 2026 Aide Memoire (opens original article in a new tab)

Teva Pharmaceutical Industries Ltd. released a Q2 2026 Aide Memoire to inform investors ahead of its second quarter results, scheduled for July 29, 2026, containing prior data and business outlook.

• Teva Pharmaceutical Industries Ltd. released a Q2 2026 Aide Memoire for investors.
• The document includes prior results, management commentary, and independent data to prepare for second quarter 2026 results scheduled for July 29, 2026.
• Teva is a biopharmaceutical company focusing on generics, biosimilars, and innovative medicines.